PCN14 CLINICAL CONSEQUENCES OF PRIMARY PROPHYLAXIS WITH PEGFILGRASTIM VERSUS FILGRASTIM FOR THE PREVENTION OF FEBRILE NEUTROPENIA IN NON-HODGKIN LYMPHOMA AND STAGE II BREAST CANCER PATIENTS IN GERMANY

Nov 1, 2010, 00:00
10.1016/S1098-3015(11)71911-8
https://www.valueinhealthjournal.com/article/S1098-3015(11)71911-8/fulltext
Title : PCN14 CLINICAL CONSEQUENCES OF PRIMARY PROPHYLAXIS WITH PEGFILGRASTIM VERSUS FILGRASTIM FOR THE PREVENTION OF FEBRILE NEUTROPENIA IN NON-HODGKIN LYMPHOMA AND STAGE II BREAST CANCER PATIENTS IN GERMANY
Citation : https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(11)71911-8&doi=10.1016/S1098-3015(11)71911-8
First page : A253
Section Title : RESEARCH POSTER ABSTRACTS
Open access? : No
Section Order : 70
Categories :
Tags :
Regions :
ViH Article Tags :